Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian Cancer
Creatinine clearance is a risk factor for severe hematologic toxicity. A creatinine clearance value <47.0 ml/min may slightly increase the risk of this toxicity in patients with ovarian cancer receiving niraparib.
Authors
- Shiori Yamada
- Michio Kimura (ORCID: https://orcid.org/0000-0002-9967-5336)
- Rina Matsuyama
- Makiko Go (ORCID: https://orcid.org/0009-0001-6499-7060)
- Eiseki Usami (ORCID: https://orcid.org/0000-0002-3422-3072)
Institutions
- Ogaki Municipal Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-05-03
- DOI
- https://doi.org/10.21873/cdp.10450
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00